Trial Profile
A six-month, chronic efficacy and safety study of eszopiclone in adult subjects with primary insomnia: a randomized double-blind, placebo-controlled study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2024
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Sunovion Pharmaceuticals
- 12 Oct 2006 New trial record.